In cancer patients, the health of the thymus—a key part of the body's immune system—is associated with the outcomes these patients experience after immune checkpoint inhibitor treatment, according to an international study reported at ESMO…
The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration of tumors into major blood vessels that cause blood clots and multiorgan failure, a one-of-a-kind clinical study…
Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer. The study was…
The health of the thymus - a key part of the body's immune system - is associated with cancer patients' outcomes to immune checkpoint inhibitor treatment, according to a ground-breaking international study reported at ESMO 2025.
Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly diagnosed glioblastoma patients survive longer than others after receiving standard treatment in conjunction with the…
Merck's KEYNOTE-B96 trial shows Keytruda with chemotherapy improves survival in platinum-resistant recurrent ovarian cancer with a consistent safety profile.
The Food and Drug Administration (FDA) approved IORT in 1999. It’s a treatment that involves just a single dose of radiation to a patient’s breast tissue after surgery, compared to whole or partial breast radiation treatments.
A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong prognostic information, treatments for…
…new locally available tests enable targeted treatment, reducing costs and wait times for Nigerian cancer patients In a breakthrough for cancer care in Nigeria, Biologix Laboratories limited, a wholly owned
A sulfur-containing amino acid called cysteine could help cancer patients recover from gut damage caused by chemotherapy and radiation, MIT scientists found.
Startup Leo Cancer Care is transforming proton radiation treatment with a simple idea: having patients sit up instead of lying down. Now hospitals that include Stanford and McLaren are lining up to buy dozens of machines.
Legal action launched against pharmaceutical giant Johnson & Johnson claiming it knowingly sold Johnson's Baby Powder contaminated with asbestos, which it denies
The Federal Government has unveiled new measures to strengthen Nigeria’s cancer response, including the establishment of additional treatment centres and increased funding to expand access and ease the financial burden on patients…
A team from Huntsman Cancer Institute at the University of Utah (the U) has found that triple-negative breast cancer is fueled by lipids and that these fatty acids are a key feature of obesity that promote tumor growth. Their research,…
(MedPage Today) -- Patients enrolled in Medicare Advantage (MA) plans were less likely to receive cancer surgery at high-quality hospitals compared with traditional Medicare enrollees, a national retrospective cohort study suggested.